Inflammasomes and atherosclerosis: a mixed picture

AR Tall, KE Bornfeldt - Circulation research, 2023 - Am Heart Assoc
The CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcome Study) and colchicine
trials suggest an important role of inflammasomes and their major product IL-1β (interleukin …

Quartet of APOCs and the different roles they play in diabetes

CC Hsu, JE Kanter, V Kothari… - … , and Vascular Biology, 2023 - Am Heart Assoc
APOA1 and APOB are the structural proteins of high-density lipoprotein and APOB-
containing lipoproteins, such as low-density lipoprotein and very low-density lipoprotein …

Hematopoietic NLRP3 and AIM2 inflammasomes promote diabetes-accelerated atherosclerosis, but increased necrosis is independent of pyroptosis

CC Hsu, TP Fidler, JE Kanter, V Kothari, F Kramer… - Diabetes, 2023 - Am Diabetes Assoc
Serum apolipoprotein C3 (APOC3) predicts incident cardiovascular events in people with
type 1 diabetes, and silencing of APOC3 prevents both lesion initiation and advanced lesion …

Apolipoprotein C3: form begets function

KE Bornfeldt - Journal of Lipid Research, 2024 - ASBMB
Increased circulating levels of apolipoprotein C3 (APOC3) predict cardiovascular disease
(CVD) risk in humans, and APOC3 promotes atherosclerosis in mouse models. APOC3's …

Disturbed lipid profile in common variable immunodeficiency–a pathogenic loop of inflammation and metabolic disturbances

SF Jorgensen, ME Macpherson… - Frontiers in …, 2023 - frontiersin.org
The relationship between metabolic and inflammatory pathways play a pathogenic role in
various cardiometabolic disorders and is potentially also involved in the pathogenesis of …

A current update on the role of HDL-based nanomedicine in targeting macrophages in cardiovascular disease

A Rani, G Marsche - Pharmaceutics, 2023 - mdpi.com
High-density lipoproteins (HDL) are complex endogenous nanoparticles involved in
important functions such as reverse cholesterol transport and immunomodulatory activities …

APOC3 siRNA and ASO therapy for dyslipidemia

J Chebli, M Larouche, D Gaudet - Current Opinion in …, 2024 - journals.lww.com
Inhibition of apoC3 is effective across all the spectrum of hypertriglyceridemia, might have a
favorable effect on hepatic steatosis (NAFLD) and the effect of apoC3 inhibition on …

Reply to: apolipoprotein C3 induces inflammasome activation only in its delipidated form

S Zewinger, J Reiser, V Jankowski, D Alansary… - Nature …, 2023 - nature.com
With a great deal of interest we read the comment related to our manuscript entitled
'Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome …

Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes

J Cervantes, J Koska, F Kramer, S Akilesh… - JCI …, 2024 - Am Soc Clin Investig
Diabetes increases the risk of both cardiovascular disease and kidney disease. Notably,
most of the excess cardiovascular risk in people with diabetes is in those with kidney …

The analysis of serum lipids profile in Guillain-Barre syndrome

L Wang, Y Ding, J Liu, G Zheng, S Li, W Jiang… - Frontiers in …, 2023 - frontiersin.org
Background Guillain-Barre syndrome (GBS) is an immune-mediated inflammatory
peripheral neuropathy. This study aimed to conduct a systematic analysis of the serum lipids …